Trial intelligence / Profile preview

Qiyetuomai Capsule in Post-stroke Recovery (Blood Stasis Obstructing Collaterals)

CTR20140048Phase 2Completed

Sponsor
Jilin Tianyao Technology
Start
Feb 2015
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Qiyetuomai Capsule in brain infarction, sponsored by Jilin Tianyao Technology. Started Feb 2015; status: completed.

02

Drugs

Qiyetuomai Capsule
03

Conditions

brain infarction

Beyond the preview

Go deeper on CTR20140048.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20140048.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call